1888PressRelease.com
1888 PressRelease Home Sign In Register About Us Sitemap
07
Mar
2008

New Report: Top Companies In Global Infectious Disease Treatment Market Need To Re-think Tactics

Report Buyer, the online destination for business intelligence for major industry sectors, has a new report which finds that some top companies will need to re-evaluate strategy as there is a slowdown in the infectious disease treatment market.

(1888PressRelease) March 07, 2008 - Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which finds that some top companies will need to re-evaluate strategy as the growth rates for the $38bn infectious disease market has fallen over the 2005-2006 period.

The report, "Commercial Insight: Infectious Diseases Overview" which is available at http://www.reportbuyer.com/go/DAT09488, finds that 10 players account for two thirds of seven major market chemotherapeutic anti-infective sales by value, but just one third by volume. It says that these companies have, collectively, been worst hit by the market slowdown, making it necessary for them to implement key changes.

Authors of the report say that the core competencies of these companies range from a single disease area to prowess in the generics field. This report characterises the key players in each sector, and their approach to maximising returns from a pressurised sector.

Analysts provide an inter and intra-sector overview of the four major components of the chemotherapeutic anti-infectives market in Japan, the US, and EU.

The report provides the disease backgrounds for each sector, drawing attention to the key clinical issues and unmet needs that shape commercial strategies for success. It outlines market size, structure, brand and company orientation by sector and highlights the winning tactics and strategies in portfolio management.

The study finds that the sluggish market has placed an increased emphasis on high value niches of the market, and the need for effective tactics to ensure revenue loss minimisation (including, for example, OTC leveraging), line extension and product succession in different measures.

The report highlights the elements of strategies that have either kept players at the top of their field or failed to facilitate growth. It also provides pointers on how businesses should position their products and services.

"Commercial Insight: Infectious Diseases Overview" is available from Report Buyer.

For more information see website.
Report Buyer product ID: DAT09488

Report Buyer is a UK-based independent online store supplying business information. The website now carries over 44,000 business information products, including market reports, studies, books and events. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. A regularly updated blog provides information on the latest market trends.

http://www.reportbuyer.com/pharma_healthcare/

###

 
 

Visit Our Site

Contact Information

E Bailey

Report Buyer

SE1 3LJ

Voice: 02070607474

Visit our Site

Press Release Tools